129 related articles for article (PubMed ID: 8237806)
1. Effects of long-term oral magnesium chloride replacement in congestive heart failure secondary to coronary artery disease.
Bashir Y; Sneddon JF; Staunton HA; Haywood GA; Simpson IA; McKenna WJ; Camm AJ
Am J Cardiol; 1993 Nov; 72(15):1156-62. PubMed ID: 8237806
[TBL] [Abstract][Full Text] [Related]
2. Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease.
Barr CS; Lang CC; Hanson J; Arnott M; Kennedy N; Struthers AD
Am J Cardiol; 1995 Dec; 76(17):1259-65. PubMed ID: 7503007
[TBL] [Abstract][Full Text] [Related]
3. Hypomagnesemia in heart failure with ventricular arrhythmias. Beneficial effects of magnesium supplementation.
Ceremuzyński L; Gebalska J; Wolk R; Makowska E
J Intern Med; 2000 Jan; 247(1):78-86. PubMed ID: 10672134
[TBL] [Abstract][Full Text] [Related]
4. Antiarrhythmic action of pharmacological administration of magnesium in heart failure: a critical review of new data.
Sueta CA; Patterson JH; Adams KF
Magnes Res; 1995 Dec; 8(4):389-401. PubMed ID: 8861138
[TBL] [Abstract][Full Text] [Related]
5. Effect of acute magnesium administration on the frequency of ventricular arrhythmia in patients with heart failure.
Sueta CA; Clarke SW; Dunlap SH; Jensen L; Blauwet MB; Koch G; Patterson JH; Adams KF
Circulation; 1994 Feb; 89(2):660-6. PubMed ID: 7508827
[TBL] [Abstract][Full Text] [Related]
6. Clinical and prognostic significance of serum magnesium concentration in patients with severe chronic congestive heart failure: the PROMISE Study.
Eichhorn EJ; Tandon PK; DiBianco R; Timmis GC; Fenster PE; Shannon J; Packer M
J Am Coll Cardiol; 1993 Mar; 21(3):634-40. PubMed ID: 8436744
[TBL] [Abstract][Full Text] [Related]
7. Determinants of the initial effects of captopril on blood pressure, glomerular filtration rate, and natriuresis in mild-to-moderate chronic congestive heart failure secondary to coronary artery disease.
Motwani JG; Fenwick MK; Morton JJ; Struthers AD
Am J Cardiol; 1994 Jun; 73(16):1191-6. PubMed ID: 8203337
[TBL] [Abstract][Full Text] [Related]
8. Value of carvedilol in congestive heart failure secondary to coronary artery disease.
Das Gupta P; Broadhurst P; Raftery EB; Lahiri A
Am J Cardiol; 1990 Nov; 66(15):1118-23. PubMed ID: 1977300
[TBL] [Abstract][Full Text] [Related]
9. The effects of piretanide, a potassium stable diuretic, on serum electrolytes in patients with congestive heart failure.
Verho M; Bückert C; Freude J; Jaeger S; Pahnke K
Pharmatherapeutica; 1985; 4(5):288-95. PubMed ID: 3906674
[TBL] [Abstract][Full Text] [Related]
10. Role of magnesium in the management of hypertension.
Shafique M; Misbah-ul-Ain ; Ashraf M
J Pak Med Assoc; 1993 Apr; 43(4):77-8. PubMed ID: 8230658
[TBL] [Abstract][Full Text] [Related]
11. Variability of hemodynamic responses to acute digitalization in chronic cardiac failure due to cardiomyopathy and coronary artery disease.
Cohn K; Selzer A; Kersh ES; Karpman LS; Goldschlager N
Am J Cardiol; 1975 Apr; 35(4):461-8. PubMed ID: 1119395
[TBL] [Abstract][Full Text] [Related]
12. Diuretics, serum and intracellular electrolyte levels, and ventricular arrhythmias in hypertensive men.
Siegel D; Hulley SB; Black DM; Cheitlin MD; Sebastian A; Seeley DG; Hearst N; Fine R
JAMA; 1992 Feb; 267(8):1083-9. PubMed ID: 1735925
[TBL] [Abstract][Full Text] [Related]
13. Effects of peroral magnesium on plasma and skeletal muscle electrolytes in patients on long-term diuretic therapy.
Dyckner T; Wester PO; Widman L
Int J Cardiol; 1988 Apr; 19(1):81-7. PubMed ID: 3372076
[TBL] [Abstract][Full Text] [Related]
14. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial.
Rodríguez-Morán M; Guerrero-Romero F
Diabetes Care; 2003 Apr; 26(4):1147-52. PubMed ID: 12663588
[TBL] [Abstract][Full Text] [Related]
15. Congestive heart failure and ventricular arrhythmias in relation to serum magnesium.
Oladapo OO; Falase AO
Afr J Med Med Sci; 2000; 29(3-4):265-8. PubMed ID: 11714003
[TBL] [Abstract][Full Text] [Related]
16. Cardiocirculatory effects of afterload reduction with oral trimazosin in severe chronic congestive heart failure.
Awan NA; Hermanovich J; Whitcomb C; Skinner P; Mason DT
Am J Cardiol; 1979 Jul; 44(1):126-31. PubMed ID: 453037
[TBL] [Abstract][Full Text] [Related]
17. [Prognosis of mild chronic heart failure: effects of the ACE inhibitor captopril].
Kleber FX; Doering W
Herz; 1991 Sep; 16 Spec No 1():283-93. PubMed ID: 1820294
[TBL] [Abstract][Full Text] [Related]
18. Effects of intravenous magnesium chloride reverse left ventricular end-diastolic pressure in coronary artery disease.
Benzer W; Schmid P; Maehr G; Drexel H
Am J Cardiol; 1996 Mar; 77(8):638-40. PubMed ID: 8610617
[No Abstract] [Full Text] [Related]
19. Placebo-controlled study of oral enoximone in congestive heart failure with initial and final intravenous hemodynamic evaluation.
Khalife K; Zannad F; Brunotte F; Belhadj K; Juilliere Y; Iannascoli F; Gilgenkrantz JM
Am J Cardiol; 1987 Aug; 60(5):75C-79C. PubMed ID: 2956874
[TBL] [Abstract][Full Text] [Related]
20. A randomized study of intravenous magnesium in acute myocardial infarction treated with direct coronary angioplasty.
Santoro GM; Antoniucci D; Bolognese L; Valenti R; Buonamici P; Trapani M; Santini A; Fazzini PF
Am Heart J; 2000 Dec; 140(6):891-7. PubMed ID: 11099993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
